Document Detail


Early intravenous beta blockade and thrombolytics in acute myocardial infarction.
MedLine Citation:
PMID:  7904119     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This article discusses therapy with beta blockade and thrombolytic agents in acute myocardial infarction. In large and well-controlled studies both treatment strategies have been shown to increase survival. Both therapies have also been demonstrated to be safe in acute myocardial infarction. Historically, the 2 different treatment strategies have been tested during different time periods, resulting in few studies with the main objective to study the combined effects of the 2 agents. From the data that are presently available, however, there is a clear suggestion of additive beneficial effect and the 2 treatments given in combination are well tolerated.
Authors:
G Olsson; P Held
Related Documents :
2240919 - Selection of patients with acute myocardial infarction for thrombolytic therapy.
11075749 - Update on intravenous fibrinolytic therapy for acute myocardial infarction.
7935639 - Knowledge and practices of generalist and specialist physicians regarding drug therapy ...
3097099 - Coronary thrombolysis with recombinant tissue-type plasminogen activator: patency rate ...
7836239 - Long-term effects of thrombolytic therapy on clinical course and left ventricular funct...
8445189 - Thrombolytic therapy in review.
8729069 - Oxidative stress as a mechanism of cardiac failure in chronic volume overload in canine...
8595059 - Comparison of the cardioprotective efficacy of superoxide dismutase in a single and a r...
11231429 - Design and rationale of the arbiter trial (arterial biology for the investigation of th...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The American journal of cardiology     Volume:  72     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1993 Dec 
Date Detail:
Created Date:  1994-02-04     Completed Date:  1994-02-04     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  156G-160G     Citation Subset:  AIM; IM    
Affiliation:
Cardiovascular Medicine, Astra Hässle AB, Mölndal, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use*
Drug Therapy, Combination
Fibrinolytic Agents / therapeutic use*
Humans
Infusions, Intravenous
Myocardial Infarction / drug therapy*
Survival Analysis
Time Factors
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Fibrinolytic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Studies on background of gamma-GTP abnormality in human multiphasic screening. (Part 3): Multiple re...
Next Document:  Combined enzymatic and linkage analysis for heterozygote detection in Hunter syndrome: identificatio...